Search for: "HCA INCĀ " Results 41 - 60 of 151
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2017, 12:54 am by Mark Summerfield
  This suggests to me that the Patent Office is continuing to grapple with the principles of patent-eligibility set out in Research Affiliates, RPL Central, and D’Arcy v Myriad Genetics Inc [2015] HCA 35, and that applicants therefore still cannot expect predictable or consistent outcomes as examiners endeavour to apply these principles on a case-by-case basis. [read post]
12 Apr 2017, 4:47 pm by Stephen Page
Recently I presented at the seventh annual Family Law Forum run by Legalwise in Brisbane about third party property settlement issues. [read post]
29 Jul 2016, 11:57 pm by Mark Summerfield
  These are difficult cases at the very frontiers of patent-eligibility under the law as it stands following the Full Federal Court judgments in Research Affiliates LLC v Commissioner of Patents [2014] FCAFC 150 and Commissioner of Patents v RPL Central Pty Ltd [2015] FCAFC 177, along with the High Court judgment in D'Arcy v Myriad Genetics Inc [2015] HCA 35. [read post]
30 Jun 2016, 9:58 am by Steven Koprince
Supreme Court’s decision in Kingdomware Technologies, Inc. v. [read post]
15 Feb 2016, 5:24 am by Patrick A. Malone
” The participants include:  American Express,  American Water, BNSF Railway,  Brunswick, Caterpillar, Coca-Cola, E.I. du Pont de Nemours, HCA Inc, Hartford Financial Services, IBM,  Ingersoll Rand, International Paper, Lincoln Financial, Macy’s,  Marriott International, NextEra Energy, Pitney Bowes, Shell Oil,  Verizon Communications, and Weyerhaeuser. [read post]
5 Dec 2015, 11:59 pm by Mark Summerfield
  These provisions apply particularly to regulated products, including  pharmaceuticals and biologics (a.k.a biopharmaceuticals).In this article I will look at three specific aspects of the TPP:the obligation to provide for adjustment of the patent term to compensate for ‘unreasonable delays’ in the grant of a patent, about which I expect Australia to do nothing; the obligation to provide for extensions of the term of patents relating to pharmaceutical products as compensation… [read post]
13 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Just days after settling with the US Department of Justice (DOJ) agreeing to pay $16 million to resolve allegations of False Claims Act (FCA) violations, HCA Holdings, Inc. [read post]
13 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Just days after settling with the US Department of Justice (DOJ) agreeing to pay $16 million to resolve allegations of False Claims Act (FCA) violations, HCA Holdings, Inc. [read post]
13 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Just days after settling with the US Department of Justice (DOJ) agreeing to pay $16 million to resolve allegations of False Claims Act (FCA) violations, HCA Holdings, Inc. [read post]
11 Nov 2015, 9:00 am
Many of the hospitals comprising the settlements are among the nation's leading health care chains, including Ascension Health and 32 of its affiliated hospitals, Community Health Systems, Inc. and 31 affiliated hospitals and HCA Holdings, Inc. and 42 of its affiliated hospitals.... [read post]